Copy
Having trouble viewing this email? View it in your browser.

March 25, 2021

Subscribe subscribe-email-icon

Your one-stop source for the latest from SAMHSA.

Featured Items

SAMHSA Releases $2.5 Billion to Address Mental Illness, Addiction Crisis Worsened by COVID-19

The Biden Administration will provide nearly $2.5 billion in funding to states and territories to address the nation’s mental illness and addiction crisis, which has worsened during the COVID-19 pandemic.

SAMHSA will direct $1.65 billion in Substance Abuse Prevention and Treatment Block Grant funding and $825 million in Community Mental Health Services Block Grant funding to states and territories.

Funding

Screening, Brief Intervention, and Referral to Treatment

Application Due Date: Monday, April 19, 2021

59e0476f-0ea2-47af-bc59-3a984648f2db.png

SAMHSA is accepting applications for Screening, Brief Intervention, and Referral to Treatment (SBIRT) grants. The purpose of this program is to implement screening, brief intervention, and referral to treatment services for children, adolescents, and/or adults in primary care and community health settings (e.g., health centers, hospital systems, health maintenance organizations (HMOs), preferred-provider organizations (PPOs), Federally Qualified Health Care (FQHC) systems, behavioral health centers, pediatric health care providers, Children’s Hospitals, etc.) with a focus on screening for underage drinking, opioid use, and other substance use. These grants support clinically appropriate services for persons at risk (asymptomatic) for substance use disorder (SUD), as well as those diagnosed with SUD.

SAMHSA plans to issue approximately 10 awards of up to $995,000 per year for up to 5 years.

Provider’s Clinical Support System — Universities

Application Due Date: Tuesday, April 20, 2021

SAMHSA is accepting applications for Provider’s Clinical Support System — Universities (PCSS-Universities) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder (OUD) seeking or receiving MAT through ensuring the education and training of students in the medical, physician assistant, and nurse practitioner fields. This program’s focus is to ensure students fulfill the training requirements needed to obtain a DATA waiver to prescribe MAT in office-based settings.

SAMHSA plans to issue approximately 36 awards of up to $150,000 per year for up to 3 years.

Medication Assisted Treatment — Prescription Drug and Opioid Addiction

Application Due Date: Tuesday, April 27, 2021

SAMHSA is accepting applications for Medication-Assisted Treatment Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT.

SAMHSA plans to issue approximately 89 to 135 awards of up to $1 million per year for states and up to $525,000 per year for other domestic public or non-profit entities for up to 5 years.

Strategic Prevention Framework for Prescription Drugs

Application Due Date: Friday, April 30, 2021

SAMHSA is accepting applications for Strategic Prevention Framework for Prescription Drugs (SPF Rx) grant program. The SPF Rx grant program provides an opportunity for states, U.S. territories, (herein referred to as “states”), and Tribal entities that have completed a Strategic Prevention Framework State Incentive Grant (SPF SIG) to target the priority issue of prescription drug misuse or another state-level strategic planning process around prescription drug misuse prevention.

SAMHSA plans to issue approximately 26 awards of up to $384,000 per year for up to 5 years.

COVID-19 Information for SAMHSA Discretionary Grant Recipients

SAMHSA is allowing flexibility for grant recipients affected by the loss of operational capacity and increased costs due to the COVID-19 crisis. These flexibilities are available during this emergency time period. Flexibility may be reassessed upon issuance of new guidance by the Office of Management and Budget post the emergency time period. Continue to check for updated information and resources to assist grant recipients during the COVID-19 emergency.

Frequently Asked Questions (FAQs) Related to COVID-19 for SAMHSA Grant Recipients

These FAQs address general questions associated with award and management of SAMHSA discretionary grants that may arise in relation to COVID-19. This information does not apply to SABG, MHBG, PATH, or PAIMI grants. Applicants and grant recipients are strongly encouraged to continue to check for updated information and resources.

Training & Events
Training and Events Icon

Training and events are available for practitioners through SAMHSA’s Training and Technical Assistance Centers. Some of these are highlighted below. Visit SAMHSA’s Practitioner Training webpage for a more complete listing.

SAMHSA Headlines offers you a biweekly update of selected upcoming trainings and webinars. However, for a broader range of activities, visit this website, as well as the training sections of individual technical assistance center websites.

Selected events are highlighted below. Note that some of them require advance registration.

Note: If you are unable to access an event or webinar or have questions, please contact the source given at the individual event URL.

Positive Living: A Positive Psychology Approach to Recovery-oriented Care for People with Schizophrenia—Webinar

Friday, March 26, 2021 12:00 p.m. ET

Positive Living is a manualized intervention aimed at increasing the experience of positive emotions for people with schizophrenia. This presentation will provide an overview of the intervention and how it has been adapted from positive psychotherapy. Results will be presented from a small pilot study aimed at exploring the implementation of the group in a clinical setting. There will also be updates about a virtual adaptation of the Positive Living intervention aimed at improving the well-being of family members in an early psychosis program.

Quarterly Lecture Series—The Dangerous Health Impacts of Alcohol: from Assessment to Treatment—Webinar

Friday, March 26, 2021 1:00 p.m. ET

This Lecture Series presentation will provide current information on alcohol use disorder trends and provide strategies for clinicians to assess and treat alcohol use disorder. Participants will be able to address the synergistic effect of alcohol and secondary risk factors such as diet, viral hepatitis, and gender on the development and progression of alcoholic liver and pancreatic diseases. A panel discussion with the presenters will follow the lecture. This portion of the presentation is intended to assist providers in translating the information provided by the presenters into meaningful encounters with patients.

Stimulants 2021: Epidemiology, Effects and Treatments—Webinar

Friday, March 26, 2021 1:00 p.m. ET

This webinar will provide an overview of current research on stimulant use, how stimulant use compares to other substance use trends, and what are the current recommendations for treatment of stimulant use disorder.

Self-Care & Wellness for ALL—Webinar

Monday, March 29, 2021 12:00 p.m. ET

Always focused on helping others, professionals can experience challenges in practicing self-care for themselves. This interactive workshop provides an opportunity for providers to review wellness practices and experience the benefits of intentional, micro-structured, self-care interventions. 

Harm Reduction: Session 1—Webinar

Tuesday, March 30, 2021 2:00 p.m. ET

This three-part series will focus on the principles of harm reduction and its strategies to advance holistic services for individuals with substance use disorder (SUDs). Specifically, this webinar series will include: an overview of the principles of harm reduction and their application in a harm reduction center; the importance of engaging law enforcement especially in rural areas and co-responder models; and a panel of experts discussing their expertise in offering harm reduction strategies in their service delivery as well as a consumer of harm reduction services.

Cultural Considerations in Early Psychosis Care—Webinar

Wednesday, March 31, 2021 11:00 a.m. ET

The onset of early psychosis experiences (e.g., experiencing subthreshold or full symptoms of delusions, hallucinations, disorganization, etc.) generally occurs between the ages of 15-25, making adolescence and young adulthood critical periods for intervention. This webinar will highlight important cultural considerations (broadly defined) to integrate into early psychosis work, discuss how these factors have been addressed to date, offer practical suggestions, and propose next steps for the field.

Traumatic Brain Injury and Substance Use Disorder: Intimate Partner Violence—Webinar

Wednesday, March 31, 2021 12:30 p.m. ET

This presentation will introduce the role of domestic violence and other abusive tactics—specifically mental health and substance use coercion—as additional drivers of substance misuse and addiction. To add another layer of complexity, a critically important consequence of domestic violence has been hidden in plain sight for decades—brain injury.  This webinar will share what we have learned from groundbreaking research in Ohio on the intersection of brain injury and domestic violence, as well as a service provision framework called CARE (Connect, Acknowledge, Respond, Evaluate). You will leave with tools to assist you in raising awareness and addressing partner-inflicted brain injury in your services and help you better support the unique needs of people impacted by domestic violence, brain injury, and addiction.

Daily Cannabis Use During Pregnancy and Postpartum: Patient, Provider, and Budtender Perspectives—Webinar

Wednesday, March 31, 2021 3:00 p.m. ET

This presentation will cover a series of research studies focused on perceptions of risk of cannabis use during pregnancy and postpartum. Research participants included perinatal women, healthcare providers, and cannabis retailers in the state of Washington.

Compassion Fatigue in Clinicians Working with Vulnerable Populations—Webinar

Thursday, April 1, 2021 3:00 p.m. ET

Many clinicians are frequently exposed to and empathically engage with the firsthand accounts of others’ traumatic experiences. A clinician’s indirect exposure to trauma can result in emotional responses and symptoms that parallel PTSD. Possible reactions to a survivor’s recounting of trauma will be identified along with signs of compassion fatigue, specifically in those working with people with serious mental illness and other vulnerable populations. Tools and resources at the individual and organizational level for addressing compassion fatigue will be reviewed including EAP and other evidence based tools that can translate to working with clients.

Suicide Prevention in Latino and Indigenous Populations—Webinar

Monday, April 5, 2021 1:00 p.m. ET

Prevention strategies for Latinx and Indigenous populations are not singular nor is there one approach for all individuals or communities. Understanding the importance of cultural elements and the need to adapt any prevention strategies in order to be most effective is a primary task. This session will explore strategies to encourage new approaches to prevention and treatment. This is an intermediate level workshop designed for mental health providers, school mental health providers, and school administrators.

Effective Communication and De-escalation Techniques with Colleagues, Patients, Staff and Community Members—Webinar

Tuesday, April 6, 2021 2:00 p.m. ET; Or Wednesday, April 7, 2021 5:00 p.m. ET

Learn skills for effective communication and de-escalation techniques with colleagues, patients, staff and community members in a small group training setting with breakout rooms and a facilitated learning environment.

Forensic Mental Health Practice and Training: Expanding Programming in Washington—Webinar

Thursday, April 8, 2021 12:00 p.m. ET

This is the first of a three-part webinar series related to forensic mental health. Participants interested in this topic are encouraged to attend the series, but each presentation can be viewed independently and participation in one is not dependent on participation in other lectures in the series. This presentation will provide an overview of forensic mental health services and introduce participants to the University of Washington’s Center for Mental Health, Policy, and the Law.

PCSS Exchange Session 1—Explore, Part 1—Webinar

Thursday, April 8, 2021 3:00 p.m. ET

Have you considered prescribing Medications for Opioid Use Disorder (MOUD) to treat your patients with opioid use disorder (OUD)? Have you wondered what is required to prescribe buprenorphine or other pharmacotherapies? If you answered yes to either or both of these questions, this Providers Clinical Support System (PCSS) Exchange session could provide you with the critical information and steps in determining the readiness of your site and clinical leadership. This webinar is for physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.

Growing Your Toolkit to Effectively Serve the LGBTQ+ Community—Webinar

Friday, April 9, 2021 1:30 p.m.

This four-hour webinar will offer both the foundational knowledge needed to effectively engage with members of the LGBTQ+ community and the tools/resources necessary to support their mental health and well-being. In the first half, we will explore the basic terminology and concepts important in the LGBTQ+ community, the concepts of sex, gender, sexuality, and sexual orientation, and how labels are applied to describe one’s experience of their identity. Later, we will discuss common strategies for engaging with LGBTQ+ individuals in ways that are inclusive and honor their lived experiences, explore developmental considerations for LGBTQ+ people, various models of identity development, risk factors and resilience, and specific mental health considerations.

Contact Us

We appreciate your feedback! Please send your questions, comments, and suggestions to the SAMHSA Headlines Team. You can call us at 1-877-SAMHSA-7, or email us at SAMHSAHeadlines@samhsa.hhs.gov. We look forward to hearing from you.

You are receiving this message because of your existing relationship with SAMHSA email updates. If you no longer wish to receive SAMHSA Headlines, go to "Update My Profile" and check the box under "Check to Delete" for SAMHSA Headlines and submit. For further assistance, please contact samhsainfo@samhsa.hhs.gov.

Was this email forwarded to you? To receive future SAMHSA Headlines directly from SAMHSA, subscribe.

Substance Abuse & Mental Health Services Administration

5600 Fishers Lane Rockville, MD 20857 USA

1-877-SAMHSA-7 (1-877-726-4727) | www.samhsa.gov | Privacy
 

SAMHSA is a public health agency within the U.S. Department of Health and Human Services. Its mission is to reduce the impact of substance abuse and mental illness on America's communities.

Forwarded this by a friend? Subscribe and join over 250,000 people receiving the latest on substance use and mental health. Forward to a friend.

This email was delivered to ptobias@ncsc.org.

Mobile AppsPublications | Unsubscribe | Update My Profile | Contact Us

Copyright © 2021 Substance Abuse & Mental Health Services Administration, All rights reserved.